Integrated Eye Tracking and Neural Monitoring for TBI: Optimization

February 9, 2022 updated by: Lynita Mullins, United States Naval Medical Center, San Diego

Integrated Eye Tracking and Neural Monitoring for Enhanced Assessment of Mild TBI: Clinical Optimization Study

Traumatic brain injury (TBI) is one of the most frequent injuries affecting service members. Unfortunately, current neurocognitive assessment tools are unable to reliably detect mild TBI more than a few days post- injury. Therefore, development of advanced systems for assessment and diagnosis of TBI are a top priority within Department of Defense. This project aims to evaluate a combined electroencephalography (EEG) and eye tracking system capable of assessing compromised cognitive function stemming from TBI, with the goal of enhancing operational readiness and aiding in diagnosis, improving health care and rehabilitation for affected military personnel.

Study Overview

Status

Completed

Detailed Description

This study (N=100) will be a correlational study to assess cognitive function in healthy controls, individuals with mild TBI, and individuals with moderate-to-severe TBI.

In general, participants will provide demographic information, medical history, and details of their head injury. Participants will also complete a brief neuropsychological assessment to obtain an index of cognitive ability, along with the Fusion Test with eye tracking and linked EEG. MRI data may also be obtained.

Study Type

Observational

Enrollment (Actual)

138

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Diego, California, United States, 92134
        • Naval Medical Center San Diego

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Male and female service members with or without traumatic brain injury (TBI).

Description

Inclusion Criteria:

All groups:

  • Ability to use dominant hand to complete cognitive and motor tasks
  • Fluent in English

Mild TBI group:

  • History of mild TBI > 3 months and < 10 years prior to enrollment
  • Self-report of post-concussive symptoms

Moderate-to-Severe TBI group:

- History of moderate or severe TBI > 3 months and < 10 years prior to enrollment

Exclusion Criteria:

Control group:

History of possible or confirmed brain injury

All groups:

  • History of a medical condition (other than brain injury) that would be expected to affect cognitive or motor abilities (e.g. muscular dystrophy, multiple sclerosis, or psychotic disorders such as schizophrenia)
  • Presence of neurological condition, such as brain tumor, brain infection, seizure, or stroke
  • Presence of visual impairment that is uncorrected by glasses or contacts (including color blindness)
  • Evidence of current suicidal or homicidal ideation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Mild TBI Group
History of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
Moderate to Severe TBI Group
History of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
Healthy Controls
No history of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EEG
Time Frame: One study visit
Spectral features and event related responses collected from scalp measurements during performance of an eye movement and working memory task.
One study visit
Eye Tracking
Time Frame: One study visit
Saccadic latencies measured in response to cognitive task including working memory demands.
One study visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neurobehavioral Symptom Inventory (NSI)
Time Frame: One study visit
Self-report measure of post-concussive symptoms
One study visit
Trail Making Test
Time Frame: One study visit
Consists of Part A and B which depends on psychomotor speed, visual search abilities, and placing demands on working memory and cognitive flexibility
One study visit
Symbol Search
Time Frame: One study visit
Wechsler Adult Intelligence Scale- Fourth Edition (WAIS-IV) Symbol Search measures information processing speed
One study visit
Digit Span
Time Frame: One study visit
WAIS-IV Digit Span including Digit Span Forward, Digit Span Backward, and Digit Span Sequencing, which measures memory span.
One study visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2017

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

October 3, 2017

First Submitted That Met QC Criteria

February 23, 2018

First Posted (Actual)

March 1, 2018

Study Record Updates

Last Update Posted (Actual)

February 11, 2022

Last Update Submitted That Met QC Criteria

February 9, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Subscribe